Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03930381 · ClinicalTrials.gov registry record · NA
Adapting and Expanding the Asthma-Educator App
A NA study of Asthma, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT03930381 is a NA study of Asthma that has completed, run by Montefiore Medical Center. The registered enrollment target is 80 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03930381, a NA study of Asthma, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
This project seeks to test and refine an adapted/expanded version of a previously created ASTHMAXcel app.
Conditions Studied
Interventions
- OTHER ASTHMAXcel App
Study Locations (1)
New York
- Montefiore Medical Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2018-05-01 |
| Est. Completion | 2023-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03930381
The ClinicalTrials.gov registry entry for NCT03930381 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (95% lower). The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which ASTHMAXcel App is the first listed.
NCT03930381 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03930381 about?
NCT03930381 is a clinical study titled "Adapting and Expanding the Asthma-Educator App". This project seeks to test and refine an adapted/expanded version of a previously created ASTHMAXcel app.
What is the current status of trial NCT03930381?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2018-05-01. Estimated completion is 2023-07-01.
What conditions does trial NCT03930381 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT03930381?
The interventions under investigation include: ASTHMAXcel App (OTHER).
Who is sponsoring clinical trial NCT03930381?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03930381 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
ASTHMAXcel Voice Study
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Asthma and Technology in Emerging African American Adults
RECRUITING · NA
-
BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.